$1.8M Bet On This Stock? Check Out These 3 Stocks Insiders Are Buying

Author: Lisa Levin | November 20, 2023 07:40am

Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Eastern Company

• The Trade: The Eastern Company (NASDAQ:EML) Director Fredrick Disanto acquired a total of 5,000 shares an average price of $18.61. To acquire these shares, it cost around $93,072.
• What’s Happening: Eastern Co reported a decline in third-quarter EPS.
• What Eastern Company Does: The Eastern Co manages industrial businesses that design, manufacture and sell engineered solutions to industrial markets.

ASA Gold and Precious Metals

• The Trade: ASA Gold and Precious Metals Limited (NYSE:ASA) 10% owner Boaz Weinstein acquired a total of 135,281 shares at an average price of $13.59. To acquire these shares, it cost around $1.84 million.
• What’s Happening: The company’s stock fell around 15% over the past six months.
• What ASA Gold and Precious Metals Does: ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company.

Don’t forget to check out our premarket coverage here

Perrigo Company

• The Trade: Perrigo Company plc (NYSE:PRGO) EVP and Chief Scientific Officer Alison Ives bought a total of 2,040 shares at an average price of $29.34. To acquire these shares, it cost around $59,854.
• What’s Happening: Perrigo reported better-than-expected third-quarter earnings.
• What Perrigo Company Does: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care.

 

Check This Out: Agilent Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Posted In: ASA EML PRGO